Comparing Ondansetron and Ginger for the treatment of nausea and vomiting in pregnancy

Comparing Ondansetron and Ginger for the treatment of nausea and vomiting in pregnancy on pregnant women attending prenatal clinic

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210303050564N1

Enrollment

150

Registered

2021-04-14

Start date

2021-04-09

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting in pregnancy. O21.0 Mild hyperemesis gravidarum

Interventions

Intervention 1: Intervention group: ondansetron Ondansetron powder is prepared from a pharmaceutical company. Then, in Tehran Shahid Beheshti School of Pharmacy, monochromatic capsules will be fille

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Gestational age 6-16 weeks Mild to moderate nausea and vomiting Single pregnancy

Exclusion criteria

Exclusion criteria: Known underlying disease Risk of pregnancy Take anticoagulants Known insensitivity to ginger and ondansetron

Design outcomes

Primary

Measure	Time frame
The severity of nausea and vomiting. Timepoint: Measure the severity of nausea and vomiting at the beginning of the study and daily during treatment. Method of measurement: Rhodes Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaraz Mojab

Shahid Beheshti University of Medical Sciences

sfmojab@yahoo.com+98 21 8820 9627

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026